Goldman Sachs invest $230M in CRO on the back of the decentralised trials craze CONTEXT: Goldman Sachs joins the decentralised trial Gold rush to invest in the contract clinical research Continue Reading
CONTEXT: Report of retrospective analysis of blood samples by the NIH in the US sheds light on the origins of the pandemic in the US. By analysing new antibody tests Continue Reading
CONTEXT: More evidence of the increasing focus on RWE, with Aetion securing another significant round of funding. The company reports doubling of revenues last year and is planning to expand Continue Reading
CONTEXT: Increased backing for the post-COVID era decentralised clinical trials. Can’t help thinking that this feels like a dot com bubble that will burst when the first major safety concerns Continue Reading
CONTEXT: As the parent of a son who is still undiagnosed but probably has a Fragile X like syndrome, this news is extremely heartening. To see Real-World Data being used Continue Reading
CONTEXT: Oncology news article on use of RWR in oncology. Nothing new in terms of data use, more confirmation of RWD in oncology research. However, an interesting perspective from the Continue Reading
CONTEXT: European initiative to explore “In-Silico” research. Not so much “Real World” as “Brave New World” utilising computer models to test safety and efficacy of medical devices. Hopefully this isn’t Continue Reading
